Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Johannes E, Wolff"'
Autor:
Junichiro Yuda, Christine Will, Darren C. Phillips, Linu Abraham, Cory Alvey, Abraham Avigdor, Wayne Buck, Lauren Besenhofer, Erwin Boghaert, Dong Cheng, Dan Cojocari, Kelly Doyle, T. Matthew Hansen, Kevin Huang, Eric F. Johnson, Andrew S. Judd, Russell A. Judge, John C. Kalvass, Aaron Kunzer, Lloyd T. Lam, Rachel Li, Ruth L. Martin, Anthony Mastracchio, Mike Mitten, Adam Petrich, Jin Wang, James E. Ward, Haichao Zhang, Xilu Wang, Johannes E. Wolff, Katherine M. Bell-McGuinn, Andrew J. Souers
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-14 (2023)
Abstract Background MCL-1 is a prosurvival B-cell lymphoma 2 family protein that plays a critical role in tumor maintenance and survival and can act as a resistance factor to multiple anticancer therapies. Herein, we describe the generation and chara
Externí odkaz:
https://doaj.org/article/a09a2953c50e4da8ad9915dfa149ffac
Autor:
Narendra Bharathy, Noah E. Berlow, Eric Wang, Jinu Abraham, Teagan P. Settelmeyer, Jody E. Hooper, Matthew N. Svalina, Zia Bajwa, Martin W. Goros, Brian S. Hernandez, Johannes E. Wolff, Ranadip Pal, Angela M. Davies, Arya Ashok, Darnell Bushby, Maria Mancini, Christopher Noakes, Neal C. Goodwin, Peter Ordentlich, James Keck, Douglas S. Hawkins, Erin R. Rudzinski, Atiya Mansoor, Theodore J. Perkins, Christopher R. Vakoc, Joel E. Michalek, Charles Keller
Publikováno v:
Skeletal Muscle, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in the pediatric cancer population. Survival among metastatic RMS patients has remained dismal yet unimproved for years. We previously identified the class I-specific h
Externí odkaz:
https://doaj.org/article/61f97051a5764d4b94672ae99d9ce9fa
Autor:
Holger Ottensmeier, Paul G Schlegel, Matthias Eyrich, Johannes E Wolff, Björn-Ole Juhnke, Katja von Hoff, Stefanie Frahsek, Rene Schmidt, Andreas Faldum, Gudrun Fleischhack, Andre von Bueren, Carsten Friedrich, Anika Resch, Monika Warmuth-Metz, Jürgen Krauss, Rolf D Kortmann, Udo Bode, Joachim Kühl, Stefan Rutkowski
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227693 (2020)
Young children with brain tumours are at high risk of developing treatment-related sequelae. We aimed to assess neuropsychological outcomes 5 years after treatment. This cross-sectional study included children under 4 years of age with medulloblastom
Externí odkaz:
https://doaj.org/article/33984af1a3a64c36ae92d87e3ec534ff
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Acute myeloid leukemia (AML) is an aggressive clonal bone marrow cancer characterized by high rates of relapse and mortality. A middle-aged woman with AML relapsed twice after achieving complete remission with induction therapy and subsequent salvage
Externí odkaz:
https://doaj.org/article/fbc36e6b50c54c0f8ae86fdfb37c05f7
Autor:
Werner Paulus, Wei Zheng, Johannes E. Wolff, Brigitte Wrede, Nicole Schmitz, Manuel Tomm, Astrid Jeibmann, Heike Stegemann, Barbara Riesmeier, Björn Koos, Sonja Mertsch, Martin Hasselblatt
The pathogenesis of choroid plexus papillomas, intraventricular papillary neoplasms most often occurring sporadically in children and young adults, remains poorly understood. To identify pathways operative in the development of choroid plexus papillo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13feb9ab6f796b2a5277c7928057049b
https://doi.org/10.1158/0008-5472.c.6499323.v1
https://doi.org/10.1158/0008-5472.c.6499323.v1
Autor:
Werner Paulus, Wei Zheng, Johannes E. Wolff, Brigitte Wrede, Nicole Schmitz, Manuel Tomm, Astrid Jeibmann, Heike Stegemann, Barbara Riesmeier, Björn Koos, Sonja Mertsch, Martin Hasselblatt
Supplementary Table 1 from TWIST-1 Is Overexpressed in Neoplastic Choroid Plexus Epithelial Cells and Promotes Proliferation and Invasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0113e3406c2e9928df0a25f324ae4613
https://doi.org/10.1158/0008-5472.22379673.v1
https://doi.org/10.1158/0008-5472.22379673.v1
Autor:
Daniel H, Albert, Neal C, Goodwin, Angela M, Davies, Jenny, Rowe, Gerold, Feuer, Michael, Boyiadzis, Kathleen A, Dorritie, Maria, Mancini, Regina, Gandour-Edwards, Brian A, Jonas, Gautam, Borthakur, Ibrahim, Aldoss, David A, Rizzieri, Olatoyosi, Odenike, Thomas, Prebet, Sanjana, Singh, Relja, Popovic, Y U, Shen, Keith F, McDaniel, Warren M, Kati, Dimple A, Modi, Monica, Motwani, Johannes E, Wolff, David J, Frost
Publikováno v:
In vivo (Athens, Greece), vol 36, iss 4
In Vivo
In Vivo
Background/Aim: The therapeutic potential of bromodomain and extra-terminal motif (BET) inhibitors in hematological cancers has been well established in preclinical and early-stage clinical trials, although as of yet, no BET-targeting agent has achie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4eba30d71a0c94f22fec4754a6d96c
https://escholarship.org/uc/item/8v66m4jc
https://escholarship.org/uc/item/8v66m4jc
Publikováno v:
The Turkish journal of pediatrics. 63(6)
Pineoblastomas (PB) are rare tumors of the central nervous system and are more common in children. There is no consensus about standard of care. The objective of this study is to analyze the outcome of children with PB.Six patients with PB who were d
Autor:
Johannes E. Wolff, Stefaan W. Van Gool, Tezer Kutluk, Blanca Diez, Rejin Kebudi, Beate Timmermann, Miklos Garami, Jaroslav Sterba, Gregory N. Fuller, Brigitte Bison, Uwe R. Kordes
Introduction Standards for chemotherapy against choroid plexus tumors (CPT) have not yet been established. Methods CPT-SIOP-2000 (NCT00500890) was an international registry for all CPT nesting a chemotherapy randomization for high-risk CPT with Carbo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7460c2012d61344b5c6808a43cc8ca1
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/93503
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/93503
Publikováno v:
Anticancer research. 42(1)
Fatigue and asthenia are common in patients with cancer; and identifying the cause as drug toxicity versus cancer progression is difficult, particularly in clinical trials without control arms.We carried out a systematic literature review of fatigue